25.05

0.68% 0.17

Progyny Inc (PGNY)

Overview News Price History Option Chain Financials Discussions Forecast

Progyny Inc stock is traded at $25.05, with a volume of 1.10M. It is up +0.68% in the last 24 hours and up +37.86% over the past month. Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Previous Close:

$24.88

Open:

$25.7

24h Volume:

1.10M

Relative Volume:

0.69

Market Cap:

$1.96B

Revenue:

$1.29B

Net Income/Loss:

$58.52M

P/E Ratio:

38.37

EPS:

0.6528

Net Cash Flow:

$191.78M

1W Performance:

+1.83%

1M Performance:

+37.86%

6M Performance:

-6.18%

1Y Performance:

+22.08%

1-Day Range:

$24.92

$25.80

1-Week Range:

$24.14

$25.90

52-Week Range:

$16.10

$28.75

Progyny Inc Stock (PGNY) Company Profile

Name

Progyny Inc

Sector

Healthcare (1111)

Industry

Healthcare Plans (12)

Phone

212-888-3124

Address

1359 BROADWAY, NEW YORK, NY

Employee

856

Twitter

@Progyny

Next Earnings Date

2026-05-07

Latest SEC Filings

PGNY's Discussions on Twitter

Compare PGNY vs UNH, CVS, ELV, CI, HUM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGNY Progyny Inc	25.05	1.95B	1.29B	58.52M	191.78M	0.6528
UNH Unitedhealth Group Inc	376.86	352.79B	449.71B	12.81B	19.67B	13.24
CVS Cvs Health Corp	90.73	118.99B	407.94B	2.90B	7.39B	2.2771
ELV Elevance Health Inc	387.85	85.71B	200.42B	5.24B	6.45B	23.50
CI Cigna Group	280.83	75.72B	278.13B	6.74B	7.66B	23.60
HUM Humana Inc	301.69	36.97B	137.20B	1.15B	1.27B	9.3439

Progyny Inc Stock (PGNY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-20-26	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform
Jan-08-26	Upgrade	Truist	Hold → Buy
Dec-09-25	Initiated	Barclays	Overweight
Nov-12-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Jul-08-25	Upgrade	Leerink Partners	Market Perform → Outperform
Dec-02-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-13-24	Downgrade	Truist	Buy → Hold
Sep-19-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Aug-07-24	Downgrade	BTIG Research	Buy → Neutral
Aug-07-24	Downgrade	Canaccord Genuity	Buy → Hold
Aug-07-24	Downgrade	Leerink Partners	Outperform → Market Perform
Jul-16-24	Initiated	JMP Securities	Mkt Outperform
May-10-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-26-24	Initiated	Leerink Partners	Outperform
Jan-03-24	Initiated	Barclays	Overweight
Sep-27-23	Initiated	Canaccord Genuity	Buy
May-22-23	Initiated	BTIG Research	Buy
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Jan-05-23	Downgrade	SVB Leerink	Outperform → Mkt Perform
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight
Sep-07-22	Initiated	Truist	Buy
Dec-02-21	Initiated	Jefferies	Buy
Nov-22-21	Downgrade	Citigroup	Buy → Neutral
Sep-30-21	Initiated	Berenberg	Buy
Aug-12-21	Initiated	Barclays	Overweight
Jun-02-21	Downgrade	Guggenheim	Buy → Neutral
Apr-29-21	Resumed	JP Morgan	Overweight
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy
Jul-01-20	Initiated	SVB Leerink	Outperform
Jun-02-20	Initiated	Guggenheim	Buy
Nov-19-19	Initiated	Citigroup	Buy
Nov-19-19	Initiated	Goldman	Buy
Nov-19-19	Initiated	JP Morgan	Overweight
Nov-19-19	Initiated	Piper Jaffray	Overweight
Nov-19-19	Initiated	SVB Leerink	Outperform

View All

Progyny Inc (PGNY)

Progyny Inc Stock (PGNY) Company Profile

Compare PGNY vs UNH, CVS, ELV, CI, HUM

Progyny Inc Stock (PGNY) Upgrades & Downgrades

Progyny Inc Stock (PGNY) Latest News

Progyny sets $200M share repurchase program - MSN

Progyny (PGNY) director receives RSUs, stock options in lieu of cash - Stock Titan

Progyny (PGNY) grants RSUs and stock options to director Dean Lloyd H - Stock Titan

Progyny (PGNY) director Kevin Gordon awarded RSUs and options in new equity grants - Stock Titan

Progyny (PGNY) director Roger Holstein receives RSUs and stock option awards - Stock Titan

Director at Progyny (NASDAQ: PGNY) receives RSUs and stock options grant - Stock Titan

Equity grants to Progyny (PGNY) director Payson Norman detailed in Form 4 - Stock Titan

Cheryl Scott (NASDAQ: PGNY) gets new RSU and stock option grants - Stock Titan

Progyny (PGNY) director Debra L. Morris granted RSUs and options in lieu of cash - Stock Titan

Progyny, Inc. authorizes a Buyback Plan. - marketscreener.com

Progyny, Inc. announces an Equity Buyback for $200 million worth of its shares. - marketscreener.com

Progyny announces $200M share repurchase program funded from cash - TradingView

Progyny (PGNY) board authorizes cash-funded $200 million stock buyback - Stock Titan

Progyny authorizes $200 million share buyback program - Investing.com

Women’s health firm Progyny launches $200M stock buyback plan - Stock Titan

Progyny, Inc. Announces Share Repurchase Program - Yahoo Finance

Progyny (PGNY) Is Up 7.0% After Analyst Upgrade Backed By Six Earnings Beats And 2026 Outlook - Yahoo Finance

Does Progyny (PGNY) Still Deserve a Premium Narrative After Its Latest Growth Upgrade and Conference Spotlight? - simplywall.st

Fertility benefits growth and share buybacks keep Progyny (PGNY) earnings in focus - MSN

[144] Progyny, Inc. SEC Filing - Stock Titan

Progyny Inc Annual Shareholders Meeting Transcript - GuruFocus

Progyny Inc (PGNY) Stock Down 3.8% -- Now Undervalued? GF Score: 87/100 - GuruFocus

Insider Sell Alert: Mark Livingston Sells Shares of Progyny Inc (PGNY) - GuruFocus

Progyny CFO Mark S. Livingston sells $211,012 of common stock By Investing.com - Investing.com Canada

Progyny CFO Mark S. Livingston sells $211,012 of common stock - Investing.com

Transcript : Progyny, Inc.Shareholder/Analyst Call - marketscreener.com

Progyny (PGNY) CFO sells 8,275 shares under Rule 10b5-1 plan - Stock Titan

Progyny (PGNY) COO Melissa Cummings sells 9,578 shares under 10b5-1 plan - Stock Titan

Progyny stock (US74340E1038): insider share sale filing puts focus on fertility benefits specialist - AD HOC NEWS

Progyny (PGNY) Stock Is Up, What You Need To Know - Yahoo Finance

PGNY Technical Analysis | Trend, Signals & Chart Patterns | PROGYNY INC (NASDAQ:PGNY) - ChartMill

Bull of the day: Progyny (PGNY) - MSN

Notice of proposed sale for PGNY (NASDAQ: PGNY) with recent RSU vesting - Stock Titan

Positive Report for Progyny (PGNY) from Goldman Sachs - The Globe and Mail

CCORF Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30 - Moomoo

PGNY Upgraded by Canaccord Genuity -- Price Target Raised to $30 - GuruFocus

Dow Theory LettersProgyny (PGNY) Stock Is Up, What You Need To Know - FinancialContent

This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga

Canaccord upgrades Progyny stock rating to buy on guidance beat streak - Investing.com Nigeria

Canaccord Genuity Upgrades Progyny to Buy From Hold, Adjusts PT to $30 From $19 - Moomoo

Canaccord upgrades Progyny stock rating to buy on guidance beat streak By Investing.com - Investing.com South Africa

Responsive Playbooks and the PGNY Inflection - Stock Traders Daily

Canaccord Genuity upgrades Progyny (PGNY) - MSN

Progyny Is Maintained at Overweight by Barclays - Moomoo

Progyny (PGNY) Stock Forecast & Analyst Ratings - Moomoo

Progyny and Standex International have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research

Bull of the Day: Progyny (PGNY) - InteractiveCrypto

Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

US proposes rule for employer-sponsored fertility benefits - MSN

Progyny stock (US74340E1038): fertility benefits specialist back in focus after strong quarterly update - facilitiesmanagement-now.com

Progyny, Inc. $PGNY Shares Sold by Thrivent Financial for Lutherans - MarketBeat

Progyny Inc Stock (PGNY) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to PGNY